Migraine


×
Rating : Rate It:
 
 
maiko gogichaishvili    on Jul 15, 2013 Says :

its great...
bhupi    on Nov 22, 2011 Says :

very useful
iqbal    on Oct 08, 2011 Says :

very useful...thanks
prakash    on Aug 14, 2011 Says :

very useful
praveen    on Jul 13, 2011 Says :

niceeeeeee
Harkesh    on Jun 09, 2011 Says :

alternative of medicine like vasogrin
Post a comment
    Post Comment on Twitter
Comments:  
11 Favorites
dr.almohamadi,   favourited this   2 Years ago.
Akhter HamidL5n,NICVD   favourited this   2 Years ago.
medic38,   favourited this   3 Years ago.
Atieno,   favourited this   3 Years ago.
Kiran Umatia,   favourited this   4 Years ago.
bogota,   favourited this   4 Years ago.
viswanathan,SV clinc bangalore   favourited this   4 Years ago.
karlmd09,   favourited this   5 Years ago.
draamirlnh,   favourited this   5 Years ago.
First Prev [1] 2 Next Last



  Notes
 
 
1 : MANAGAMENT OF MIGRAINE
2 : Migraine Facts Migraine is one of the common causes of recurrent headaches According to IHS, migraine constitutes 16% of primary headaches Migraine afflicts 10-20% of the general population More than 2/3 of migraine sufferers either have never consulted a doctor or have stopped doing so Migraine is underdiagnosed and undertreated Migraine greatly affects quality of life. The WHO ranks migraine among the world’s most disabling medical illnesses
3 : Burden Of Migraine World - 15-20% of women and 10-15% of men suffer from migraine In India, 15-20% of people suffer from migraine Adults – Female: Male ratio is 2 : 1 In childhood migraine, boys and girls are affected equally until puberty, when the predominance shifts to girls. NEJM 2002; 346(4): 257-269; XI Congress of the IHS, 2004
4 : Migraine - Definition “Migraine is a familial disorder characterized by recurrent attacks of headache widely variable in intensity, frequency and duration. Attacks are commonly unilateral and are usually associated with anorexia, nausea and vomiting” -World Federation of Neurology
5 : Migraine Triggers Food Disturbed sleep pattern Hormonal changes Drugs Physical exertion Visual stimuli Auditory stimuli Olfactory stimuli Weather changes Hunger Psychological factors
6 : Phases of Acute Migraine Prodrome Aura Headache Postdrome
7 : PRODROME Vague premonitory symptoms that begin from 12 to 36 hours before the aura and headache Symptoms include Yawning Excitation Depression Lethargy Craving or distaste for various foods Duration – 15 to 20 min
8 : AURA Aura is a warning or signal before onset of headache Symptoms Flashing of lights Zig-zag lines Difficulty in focussing Duration : 15-30 min
9 : HEADACHE Headache is generally unilateral and is associated with symptoms like: Anorexia Nausea Vomiting Photophobia Phonophobia Tinnitus Duration is 4-72 hrs
10 : POSTDROME (RESOLUTION PHASE) Following headache, patient complains of Fatigue Depression Severe exhaustion Some patients feel unusually fresh Duration: Few hours or up to 2 days
11 : MIGRAINE – CLASSIFICATION According to Headache Classification Committee of the International Headache Society, Migraine has been classified as: Migraine without aura (common migraine) Migraine with aura (classic migraine) Complicated migraine
12 : MIGRAINE: CLINICAL FEATURES
13 : MIGRAINE - PATHOPHYSIOLOGY VASCULAR THEORY Intracerebral blood vessel vasoconstriction – aura Intracranial/Extracranial blood vessel vasodilation – headache SEROTONIN THEORY Decreased serotonin levels linked to migraine Specific serotonin receptors found in blood vessels of brain PRESENT UNDERSTANDING Neurovascular process, in which neural events result in activation of blood vessels, which in turn results in pain and further nerve activation
14 : NEUROVASCULAR PROCESS
15 : Arterial Activation Release of Neurotransmitter Worsening of Pain
16 : MIGRAINE: DIAGNOSIS Medical History Headache diary Migraine triggers Investigations (only to exclude secondary causes) EEG CT Brain MRI
17 : DIFFERENTIATING COMMON PRIMARY HEADACHES Strictly unilateral Tension headaches: Do not have the associated features like nausea, vomiting, photophobia, phonophobia. The muscle contraction leads to headache. Headache quality is of a tightening (non-pulsating) quality. Usually bilateral. Intensity is mild or moderate Cluster headaches: Severe unilateral pain. Headache associated with lacrimation, nasal congestion, rhinorrhea, facial sweating or eyelid edema. Pain lasts for 15 to 180 minutes. More common in men
18 : THE TREATMENT APPROACH TO MIGRAINE
19 : LONG-TERM TREATMENT GOALS FOR THE MIGRAINE SUFFERER Reducing the attack frequency and severity Avoiding escalation of headache medication Educating and enabling the patient to manage the disorder Improving the patient’s quality of life
20 : MIGRAINE MANAGEMENT Non-pharmacological treatment Identification of triggers Meditation Relaxation training Psychotherapy Pharmacotherapy non-specific Abortive therapy specific Preventive therapy
21 : MIGRAINE: ABORTIVE THERAPY Non-specific treatment
22 : ABORTIVE THERAPY FOR MIGRAINE Specific treatment
23 : ANTI-NAUSEANT DRUGS FOR MIGRAINE TREATMENT
24 : WHY THE NEED FOR PROPHYLAXIS ? Abortive drugs should not be used more than 2-3 times a week Long-term prophylaxis improves quality of life by reducing frequency and severity of attacks 80% of migraineurs may require prophylaxis
25 : WHEN IS PROPHYLAXIS INDICATED? According to the US Headache Consortium Guidelines, indications for preventive treatment include: Patients who have very frequent headaches (more than 2 per week) Attack duration is > 48 hours Headache severity is extreme Migraine attacks are accompanied by prolonged aura Unacceptable adverse effects occur with acute migraine treatment Contraindication to acute treatment Migraine substantially interferes with the patient’s daily routine, despite acute treatment Special circumstances such as hemiplegic migraine or attacks with a risk of permanent neurologic injury Patient preference
26 : PREVENTIVE THERAPY FOR MIGRAINE
27 : PREVENTIVE THERAPY FOR MIGRAINE (CONTD.)
28 : ROLE OF BETA BLOCKERS IN MIGRAINE PROPHYLAXIS ‘Gold standard’ in migraine prophylaxis Established efficacy and safety in migraine prophylaxis Especially preferred if hypertension or anxiety co-exist
29 : ROLE OF PROPRANOLOL IN MIGRAINE PROPHYLAXIS
30 : PROPRANOLOL – MECHANISMS OF ACTION Mechanisms proposed Vasoconstriction Anxiolytic action Decreased sympathetic activity
31 : LIMITATIONS OF IMMEDIATE-RELEASE PROPRANOLOL Short t½ of 3-5 hrs Multiple daily dosing required to maintain adequate degree of beta-receptor blockade throughout 24 hr Poor patient compliance may compromise efficacy
32 : ADVANTAGES OF EXTENDED-RELEASE PREPARATION OF PROPRANOLOL Migraine patients are asymptomatic between attacks Important to minimize number of daily doses during prophylactic treatment Once-daily administration improves compliance Stable drug concentration for 24 hrs
33 : PROPRANOLOL-LA CLINICAL EFFICACY IN MIGRAINE
34 : Cephalalgia 1990; 10: 101-105 n = 51 Duration = 12 weeks PROPRANOLOL REDUCES THE FREQUENCY OF ATTACKS PER MONTH IN BOTH COMMON AS WELL AS CLASSIC MIGRAINE PATIENTS Propranolol-LA 80 mg appears to have adequate prophylactic effect for migraine and may be better tolerated than propranolol-LA 160 mg, which appears to offer no additional benefits. *p < 0.001
35 : Propranolol long-acting reduces the attack severity * p = 0.003 Headache 1998; 28: 607-611 n = 48
36 : Propranolol vs. Flunarizine 48 50 0 10 20 30 40 50 60 70 Flunarizine (p<0.01) Propranolol (p<0.0005) No. of attacks reduced by more than 50% % of Patients Headache 1989; 29: 218-223
37 : Propranolol showed a significant reduction in the severity of attacks 1.6 1.6 1.4 1.2* 0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 Flunarizine Propranolol Severity score Baseline 16 weeks * p<0.05 Headache 1989; 29: 218-223
38 : Propranolol significantly reduced the number of analgesics used 4.5 6.3 4.1 3.4 0 1 2 3 4 5 6 7 Flunarizine Propranolol Baseline 16 weeks No of analgesics/month * Headache 1989; 29: 218-223 *p<0.0005
39 : DOSAGE OF PROPRANOLOL Starting dose: 40-80 mg once daily Max. dose/day: 240 mg If satisfactory response is not obtained within 4-6 weeks, after reaching the maximal dose, therapy should be discontinued Taper slowly to avoid rebound headache and adrenergic side effects Max. duration: 9 to 12 months
40 : SHIFTING PATIENT FROM IR TO ER Propranolol extended-release produces low blood levels as compared to immediate-release The dose of the long-acting formulation may need to be higher than the total daily dose of the conventional formulation

 

Add as Friend By : Andrew
Added On : 6 Years ago.
PowerPoint Slide Presentation on
Views 19346 | Favourite 12 | Total Upload :684

Embed Code:

Flag as inappropriate


Related  Most Viewed



Free Powerpoint Templates



 



Medical PowerPoint Templates | Powerpoint Templates | Tags | Contact | About Us | Privacy | FAQ | Blog

© Slideworld